M. Guzmán

1.5k total citations
37 papers, 1.2k citations indexed

About

M. Guzmán is a scholar working on Molecular Biology, Pharmaceutical Science and Public Health, Environmental and Occupational Health. According to data from OpenAlex, M. Guzmán has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Pharmaceutical Science and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in M. Guzmán's work include Advanced Drug Delivery Systems (12 papers), Drug Solubulity and Delivery Systems (6 papers) and Corneal Surgery and Treatments (5 papers). M. Guzmán is often cited by papers focused on Advanced Drug Delivery Systems (12 papers), Drug Solubulity and Delivery Systems (6 papers) and Corneal Surgery and Treatments (5 papers). M. Guzmán collaborates with scholars based in Spain, United States and Netherlands. M. Guzmán's co-authors include M.R. Aberturas, Jesús Molpeceres, Irene T. Molina‐Martínez, Rocío Herrero‐Vanrell, J.M. Benítez-del-Castillo, Marta Vicario‐de‐la‐Torre, Beatriz de las Heras, Irene Bravo‐Osuna, Eva Aladro Vico and Manuel Rodrı́guez-Puyol and has published in prestigious journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences and Journal of Antimicrobial Chemotherapy.

In The Last Decade

M. Guzmán

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Guzmán Spain 20 564 317 301 212 114 37 1.2k
J. K. Pandit India 17 901 1.6× 285 0.9× 193 0.6× 317 1.5× 114 1.0× 39 1.4k
Th.F. Vandamme France 9 569 1.0× 180 0.6× 257 0.9× 168 0.8× 139 1.2× 10 1.2k
Hákon Hrafn Sigurðsson Iceland 19 710 1.3× 142 0.4× 256 0.9× 201 0.9× 130 1.1× 44 1.1k
Amal K. Hussein Egypt 16 482 0.9× 386 1.2× 500 1.7× 180 0.8× 91 0.8× 33 1.4k
Yıldız Özsoy Türkiye 24 862 1.5× 363 1.1× 325 1.1× 149 0.7× 107 0.9× 82 1.8k
Hanan Refai Egypt 15 660 1.2× 164 0.5× 198 0.7× 199 0.9× 66 0.6× 23 983
Tingting Peng China 20 628 1.1× 200 0.6× 267 0.9× 155 0.7× 122 1.1× 81 1.6k
Islam A. Khalil Egypt 20 415 0.7× 405 1.3× 204 0.7× 120 0.6× 67 0.6× 53 1.2k
Haibing He China 24 884 1.6× 435 1.4× 433 1.4× 102 0.5× 64 0.6× 89 1.7k
Shivani Rai Paliwal India 21 570 1.0× 539 1.7× 566 1.9× 149 0.7× 57 0.5× 37 1.6k

Countries citing papers authored by M. Guzmán

Since Specialization
Citations

This map shows the geographic impact of M. Guzmán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Guzmán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Guzmán more than expected).

Fields of papers citing papers by M. Guzmán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Guzmán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Guzmán. The network helps show where M. Guzmán may publish in the future.

Co-authorship network of co-authors of M. Guzmán

This figure shows the co-authorship network connecting the top 25 collaborators of M. Guzmán. A scholar is included among the top collaborators of M. Guzmán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Guzmán. M. Guzmán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bravo‐Osuna, Irene, Vanessa Andrés‐Guerrero, Marta Vicario‐de‐la‐Torre, et al.. (2022). Novel Osmoprotective DOPC-DMPC Liposomes Loaded with Antihypertensive Drugs as Potential Strategy for Glaucoma Treatment. Pharmaceutics. 14(7). 1405–1405. 10 indexed citations
3.
Vicario‐de‐la‐Torre, Marta, Eva Aladro Vico, Laura Morales‐Fernández, et al.. (2018). Novel Nano-Liposome Formulation for Dry Eyes with Components Similar to the Preocular Tear Film. Polymers. 10(4). 425–425. 39 indexed citations
4.
Molina‐Martínez, Irene T., et al.. (2017). Novel liposome-based and in situ gelling artificial tear formulation for dry eye disease treatment. Contact Lens and Anterior Eye. 41(1). 93–96. 42 indexed citations
5.
Guzmán, M., et al.. (2016). Pharmaceutical technology can turn a traditional drug, dexamethasone into a first-line ocular medicine. A global perspective and future trends. International Journal of Pharmaceutics. 516(1-2). 342–351. 66 indexed citations
6.
Bravo‐Osuna, Irene, Marta Vicario‐de‐la‐Torre, Vanessa Andrés‐Guerrero, et al.. (2016). Novel Water-Soluble Mucoadhesive Carbosilane Dendrimers for Ocular Administration. Molecular Pharmaceutics. 13(9). 2966–2976. 48 indexed citations
7.
Bravo‐Osuna, Irene, et al.. (2016). Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administration. European Journal of Pharmaceutical Sciences. 92. 287–297. 35 indexed citations
8.
Vicario‐de‐la‐Torre, Marta, J.M. Benítez-del-Castillo, Eva Aladro Vico, et al.. (2014). Design and Characterization of an Ocular Topical Liposomal Preparation to Replenish the Lipids of the Tear Film. Investigative Ophthalmology & Visual Science. 55(12). 7839–7847. 51 indexed citations
9.
Rincón, Sandra, Jinnethe Reyes, Lina P Carvajal, et al.. (2013). Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals. Journal of Antimicrobial Chemotherapy. 68(12). 2773–2778. 41 indexed citations
10.
Bravo‐Osuna, Irene, Rocío Herrero‐Vanrell, Igor Martínez, et al.. (2010). In vitro and in vivo Tolerance Studies of Carbosilane Dendrimers for Ophthalmic Administration. Investigative Ophthalmology & Visual Science. 51(13). 437–437. 2 indexed citations
11.
Guzmán, M., et al.. (2010). Fibroadenoma gigante de mama. Clínica e Investigación en Ginecología y Obstetricia. 38(1). 32–34. 1 indexed citations
12.
Podio, A. L., et al.. (2007). Laboratory Testing of Downhole Gas Separators. SPE Annual Technical Conference and Exhibition. 7 indexed citations
13.
Redondo, Pedro, et al.. (2007). Repigmentación del pelo canoso tras tratamiento con hormona tiroidea. Actas Dermo-Sifiliográficas. 98(9). 603–610. 17 indexed citations
14.
Guzmán, M., et al.. (2005). Parathion effects on protein synthesis in the seminiferous tubules of mice. Ecotoxicology and Environmental Safety. 65(1). 129–133. 8 indexed citations
15.
Varela, Mariana, M. Guzmán, Jesús Molpeceres, et al.. (2001). Cyclosporine-loaded polycaprolactone nanoparticles: immunosuppression and nephrotoxicity in rats. European Journal of Pharmaceutical Sciences. 12(4). 471–478. 39 indexed citations
16.
Guzmán, M., et al.. (2000). Freeze-drying of polycaprolactone and poly( d,l -lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. European Journal of Pharmaceutics and Biopharmaceutics. 50(3). 379–387. 168 indexed citations
17.
Molpeceres, Jesús, et al.. (1999). Stability and freeze-drying of cyclosporine loaded poly(d,l lactide–glycolide) carriers. European Journal of Pharmaceutical Sciences. 8(2). 99–107. 148 indexed citations
18.
Molpeceres, Jesús, et al.. (1998). Age and sex dependent pharmacokinetics of cyclosporine in the rat after a single intravenous dose. International Journal of Pharmaceutics. 174(1-2). 9–18. 10 indexed citations
19.
Molpeceres, Jesús, et al.. (1997). Stability of cyclosporine-loaded poly-X-caprolactone nanoparticles. Journal of Microencapsulation. 14(6). 777–787. 20 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026